Contraindicated (1)pentobarbital will minimize the level or result of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is accountable for the development and elimination of cariprazine's active metabolites. pentobarbital will lower the level or outcome of dapsone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Impo... https://leonardof443xnc0.aboutyoublog.com/profile